SCHEMBL4783514

SCHEMBL4783514

CC1CN(CCCCN2c3ccccc3Sc3ccc(Cl)c(O)c32)CC(C)N1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 10/20 0.45
MAPK1 P28482 5/20 0.43
CYP2D6 P10635 5/20 0.43
MAPT P10636 4/20 0.43
TP53 P04637 4/20 0.43
CYP3A4 P08684 4/20 0.43
HTR2A P28223 4/20 0.43
HTR2C P28335 4/20 0.43
HTR2B P41595 4/20 0.43
CYP2C19 P33261 4/20 0.43
SIGMAR1 Q99720 4/20 0.43
ADRA2A P08913 3/20 0.43
DRD2 P14416 3/20 0.43
ADRA2B P18089 3/20 0.43
ADRA2C P18825 3/20 0.43
SLC6A2 P23975 3/20 0.43
SLC6A4 P31645 3/20 0.43
HRH1 P35367 3/20 0.43
DRD3 P35462 3/20 0.43
LMNA P02545 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4778428 0.81 PDF (0.47) KDM1AMAPK1CYP2D6MAPTTP53
SCHEMBL11168758 0.81 KDM1A (0.65) KDM1AMAPK1CYP2D6MAPTTP53
SCHEMBL4238190 0.81 KDM1A (0.67) KDM1AMAPK1CYP2D6MAPTTP53
SCHEMBL4729385 0.81 MAPT (0.65) KDM1AMAPK1CYP2D6MAPTTP53
SCHEMBL4780685 0.80 KDM1A (0.50) KDM1AMAPK1CYP2D6MAPTTP53
SCHEMBL21436166 0.79 CYP2D6 (0.44) KDM1AMAPK1CYP2D6MAPTTP53
SCHEMBL21436165 0.79 PIM1 (0.46) KDM1AMAPK1CYP2D6MAPTTP53
SCHEMBL6863955 0.78 CYP2D6 (0.44) KDM1AMAPK1CYP2D6MAPTTP53
SCHEMBL4780730 0.78 CYP2D6 (0.45) KDM1AMAPK1CYP2D6MAPTTP53
SCHEMBL7585294 0.77 CYP2D6 (0.65) KDM1AMAPK1CYP2D6MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021745-A2 HEPATITIS C VIRUS ENTRY INHIBITORS ITHERX PHARMACEUTICALS, INC. (US) 2008-02-21 WO disclosed